• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    There are provided new compounds of the formula I <IMAGE> I wherein both R1 moieties stand for an alkyl group having 1 to 4 carbon atoms or form together a methylene bridge, R2 is cyano or an alkoxycarbonyl group having 1 to 4 carbon atoms in the alkoxy position, R3 is hydroxy or alkanoyloxy having 1 to 4 carbon atoms in the alkoxy position in alpha -position or beta -steric position, and acid addition salts thereof. There is also provided a process for the preparation of the compounds of the formula I.
    公开号:SU719499A3
    申请号:SU782626939
    申请日:1978-06-14
    公开日:1980-02-29
    发明作者:Сантаи Чаба；Сабо Лайош；Тот Иштван；Шебештьен Дьюла；Вираг Шандор；Каньо Эржебет
    申请人:Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to a method for producing new 1,2,3,4,6,7-hexahydro-P &amp; aH-benzo a quinolysin derivatives of the formula
    reduction with sodium borohydride and the fact that the 2-oxo compound of the general formula
    where both R denote an alkyl group containing 1-4 carbon atoms or together form a methylene group;
    R is a cyano or alkoxycarbonyl group in which the alkyl group contains 1-4 carbon atoms;
    R - OXI-, acetoxy group in a- or § position,
    which can be used in medicine.
    A widely known reducing agent is sodium borohydride 1.
    The purpose of the invention is the synthesis of biologically active compounds.
    This goal is achieved by the proposed method for the preparation of compounds of the indicated formula 1, based on R and R2, they have the indicated values, are treated with a reducing agent; mainly sodium borohydride, with the selection of the target product or with subsequent acylation, mainly with acetic anhydride, and the selection of the target product in free form or as a salt.
    Example 1. 2p-hydroxy-Za- (2-cyanoethyl) -9,10 - dimethoxy - 1,2,3,4,5,6,7-hexahydro-116 aH-benzo a quinolizin.
    To a suspension of 10 g (31.8 mmol) of 2-oxo-Za (2-cyanoethyl) -9,10 - dimethoxy-1,2,3,4,5,6,7 hexahydro - 116 aH-benzo and quinolysin in 120 ml of anhydrous methanol is added in portions with constant stirring, 1.2 g (31.8 mmol) of sodium borohydride at 0 ° C. After all of the reduction was added, the reaction mixture was left at room temperature with constant stirring for one hour. Highlight ;; the sediment is filtered. 4.5 mg (44%) of the title compound are obtained. From the mother liquor, another 1.1 g of product can be obtained. Thus, the overall yield is 55%. In case the filtered product contains other isomers, then this product is recrystallized from methanol and purified; so nl 160 ° C. T. pl. hydrochloride 234 ° C. Ci8H24N2O3 (mol. Weight. 316.39). Calculated,%: C 68,32; H 7.64; N 8,85. Found,%: C 68.03; H 7.65; N 8.97. IR spectrum (KVg): 3100 (-OP); 2310 (-CN); 1100 (С-О / Н) cm-1. Mass spectrum (M / e),%: 316 (100); 317 (86.7); 300 (16.3); 272 (562); 233 (67.6); 206 (74.3); 191 (60.2). Example 2. 2-a-hydroxy-Za - (2-cyanoethyl) -9,10-dimethoxy - 1,2,3,4,5,6,7-hexahydro-11HaH-benzo and quinolizin: 0.5 g of the obtained in Example 1, after separation of the 2p-hydroxy-made stock solution, thin-layer chromatography was performed on a KG-PF 254-366 plate. The carrier is a mixture of benzene and methanol in a ratio of 14: 3. Thus, a compound 2a-hydroxy is obtained. Yield 120 g (23%). Rf derivative 2a-hydroxy is higher than 2p-hydroxy-derivatives; m.p. 145 ° C. IR spectrum (KVg): 3350 (-OH); 2300 (-C N); 1065 (C-O / N) cm-i. Mass spectrum (M / e),%: 316 (M +, 5); 276 (100); 218 (24); 205 (18); 191 (22). Example 3. 2p-acetoxy-3cc- (and, ianoethyl) 9, 10 - dimethoxy - 1,2,3,4,5,6,7 - hexahydro11 &amp; a-benzo and quinolizin. 1.14 g (33.60) of the 2p-hydroxy derivative prepared in Example 1 is allowed to stand at room temperature for 24 hours after dissolving in a mixture of acetic anhydride and pyridine. The reaction mixture is dried or concentrated under vacuum, and the residue is dissolved in a small amount of water, and the pH of the residue is adjusted to 8 by adding a saturated solution of ammonium hydroxide to 8. Obtain 1.2 g of the desired compound, which corresponds to 95%. The product is purified by recrystallization from metapol, so pl. 122 ° C. The salt of the salt begins to decompose at 235 ° C. CaoHzsNsOi (358.54). Calculated,%: C 60.80; H 7.14; N 7.08. Found,%: C 60.92; H 7: 24; N 7.20. IR (KBG): at 2780 (Bolman band); 2320 (-C N); 1750 (-C O); 1230 (C-O-Cas); 1040 (C-O-C) cm-H Mass spectrum (M / e),%: 360 (M + 2) +, (&amp;0); 359 (M + 1) +, (848); 358 (M +, 35); 316 (4)); 300 (100); 298 (23); 272 (30); 247 (19); 233 (18); 206 (33). NMR spectrum (deutero-chloroform); iri 6 6.74 and 6.67 (2H, S, aromatic protons); 5.15 (W m., -CH-OCO-CH3; / 24 Hz); 4.14 (6H, S-OCH3); 2.12 (ЗН, S, -ОСО-СНз) ppm Example 4: 2cc-acetoxy-3a- (2-cyanoethyl) -9,10-dimethoxy-1,2,3,4,5,6,7-hexahydro-11 &amp; aH-benzo (quinolysin). 0.20 g (0.63 mmol) of the 2a-hydroxy derivative (example 2) is dissolved in a mixture of pyridine and acetic anhydride and left for one day at room temperature. The mixture is poured onto a small amount of ice and its pH is adjusted by adding a saturated solution of head alcohol to 8. The product which has separated out is filtered and washed with methanol. 160 mg (70%) of the title compound are obtained: mp. 148-149 ° C. IR spectrum (KVg): 300 (-C N); 1740 (-C O); 1230-1260 (C-O-Cas) cm-H C2H2bK2O4 (358.54). Calculated,%: C 60.80; H 7.14; N 7.08. Found,%: C 60.94; H 7.32; N 7.34. Mass Spectrum (M / e),%: 358 (M +, 17); 319 (3); 301 (20); 300 (100); 206 (9); 191 (6). NMP spectrum (deutero-chloroform): at, 63 (2H, S, aromatic protons); 4.78 (1H, m, -CH-OCO-CH3); 6.68 (6H, S, -COCH3); 2.15 (ЗН, S, -ОСО-СНз) ppm Example 5. 2-p-hydroxy-Za - (2-cyanrethyl) -9,10-diethoxy - 1,2,3,4,5,6,7 - hexahydro-116 aH-benzo and quinolizin. 10.0 g (29.2 mmol) of 2-oxo-Za- (cyanoethyl) -9,10 - -diethoxy-1,2,3,4,5,6,7 - hexahydro-11b-benzo and quinolysin is dissolved in 150 ml of anhydrous methanol. At 0 ° C and with constant stirring, 1.1 g (29.2 mmol) of sodium borohydride are added. Upon completion of the reaction, the reaction mixture is stirred at room temperature for one hour. The solution is neutralized with a small amount of acetic acid and evaporated under vacuum. The residue is dissolved in water, treated with saturated solution of ammonia, extracted with dichloromethane, and the organic phase is then evaporated under vacuum after drying. Over anhydrous magnesium sulphate. 9.48 g of the residue obtained is recrystallized from ethanol. 4.77 g (47.5%) of product are obtained. After some time, another 2 g (20%) of the desired compound is separated from the mother liquor. Yield 6.77 g (67.5%); m.p. 136 ° С. T. pl. hydrochloride 210 ° C. C2H28M2O3 (344.44). Calculated,%: C 69.80; H 8.20; N 8 70 Found: C 69.50; H.8.16; N 8.33.
    IR spectrum (KVg): at 3100 (OH); 2770 (Bolman band); 2270 (-C N); 1040 (CO / OH) cm-1.
    Example 6. 2p-acetoxy-3a - (2-cyanoethyl) -9,10-diethoxy - 1,2,3,4,5,6,7 - hexahydro-11 &amp; benzO and quinolysin.
    1.0 g (2.9 mmol) of the 2p-hydroxy derivative obtained in Example 5 is dissolved in 15 ml of a mixture of pyridine and acetic anhydride in a 1: 1 ratio. The reaction mixture is left at room temperature for 24 hours, then evaporated under vacuum, after which the residue is titrated with a small amount and treated with a small amount of a saturated solution of ammonia.
    750 mg (67%) of the product was isolated. The product is recrystallized from methanol; m.p. 99-102 0. T. pl. hydrochloride 245 ° C.
    C22H30N204-HC1 (423.05).
    Calculated,%: C, 62.48; H 7.39; N 6.63.
    Found,%: C 62.62; H 7.70; N 6.93.
    IR spectrum (KVg): at 2720 (Bolman band); 2300 (-C N); 1730 (-C O); 1230-1240 (C-O-Gas); 1020 (C-O-C)
    cm-1.
    NMP-spectrum (deutero-chloroform): at, 68 and 6.64 (2H, S, aromatic protons); 4.74 (W, m., -CH-OCO-CH3, 7 24 Hz); 4.18-4.92 (4H, g-OCHg-) parts / million
    Example 7. 2p-hydroxy-3- (2-methoxycarbonyloxyethyl) - 9, U-dimethoxy-1,2,3,4, 5,6,7-hexahydro - PbaN - benzo a quinolysine hydrochloride.
    3.0 g (8.64 mmol) of 2-oxo-Zapmethoxycarbonylethyl) - 9,10-dimethoxy - 1,2,3,4,5,6,7 of hexahydro-116 aH-benzo and quinolizine is converted into suspension in 50 ml of anhydrous methanol, cooled to 0 ° C, after which 220 mg of sodium borohydride are added to them evenly over 15 minutes. After adding the total amount of reducing agent, the reaction mixture is stirred for another 30 minutes.
    The mixture is then treated with known methods, the residue is dissolved in methanol and a solution of hydrochloric acid with methanol is added to it.
    2.0 g (60%) of the desired hydrochloric acid salt was isolated; m.p. 214-215 ° C. The isolated base is recrystallized from. methanol; the resulting product melts at 115 ° C.
    IR (KBG): at 3400 (-OH); 2800, 2750 (Bolman band); 1730 (-COOH) cm-1.
    Ci9H27NO5 (349.40).
    Calculated,%: C 65.35; H 7.80; N 4.02.
    Found,%: C 65.30; H 7.87; N 3.94.
    Mass spectrum (M / e): 249 (M +, 23); 248 (85); 347 (99); 303 (75); 231 (43); 204 (100); 190 (96).
    Example 8. 2a-hydroxy-3a (2-methoxycarbonylethyl) -9,10-dimethoxy-1,2,3,4,5, b, 7hexahydro-11 & a-benzo-a-quinolysin.
    The separation of the mother liquor obtained after separation of 2 (3-hydroxy derivative (see Example 7) is evaporated under vacuum, treated with sodium carbonate and extracted with dichloromethane. The organic phase is separated by separation of water through magnesium sulfate and the mixture is evaporated. The residue (0.8 g) is purified by thin layer chromatography (solvent is a mixture of benzene and methanol in a ratio of 14: 3). Yield 300 mg (10%).
    The value of Rf 2p-derivative is higher than
    the corresponding figure for the 2-derivative, so pl. 12GS.
    IR (KBG): at 3450 (-OH); 2760 (Bolman band); 1742 (-СООСНз) cm-.
    Example 9. 2p-acetoxy-Za- (2-methoxycarbonylethyl) -9,10-dimethoxy-1,2,3,4,5,6,7hexahydro-11 &amp; n-benzo and quinolizin.
    3.8 g of the crude product obtained in Example 7 is dissolved in 64 ml of a mixture of pyridine and acetic acid in a 1: 1 ratio and the mixture is left at room temperature for 24 hours: The mixture is poured into ice-cold water upon cooling and the pH is adjusted to to 8 by the addition of a saturated solution of ammonia. The precipitated product is filtered and recrystallized from methanol. The yield (based on 2-oxo-compound) is 35%, m.p. 125 ° C. T. pl. hydrochloride 238-239 ° C.
    CziHsgNOe (319.4).
    Calculated,%: C 64.43, H 7.46; N 3.57. Found,%: C 64.70; H 7.28; N 3.88. IR spectrum (KVg): at 2750 (Bolman band); 1730 (); 1220 (C-O-C) cm-.
    Mass Spectrum (M / e),%: 391 (17); 390 (51); 489 (32); 331 (100); 303 (43); 204 (35).
    Example 10. 2p-hydroxy-Za- (2-methoxycarbonylethyl) -9,10-diethoxy-1,2,3,4,5,6,7hexahydro-11 &amp; benzo-quinolysine hydrochloride.
    2.2 g (5.94 mmol) of 2-oxo-3- (2-methoxycarbonylethyl-9, 10-diethoxy - 1,2,3,4,5,6,7 hexahydro-11 &amp; benzo and a quinolysin are suspended in 40 ml of anhydrous methanol.
    The mixture is cooled to 0 ° C for 15 minutes, and 170 mg (5.96 mmol) of sodium borohydride is added to it with constant stirring. The mixture is stirred for another 20 minutes. Next, the reaction mixture is treated by the method described in the previous examples. An oily substance is obtained as a residue, which is dissolved in methanol and its pH is adjusted to 5 by addition of a solution of methanol in hydrochloric acid. The hydrochloric acid which precipitates out is filtered.
    The yield is 1.4 g (58%); m.p. 178-179 ° C. C2iH2iNOs-HCI (378.56 + 36.46).
    Calculated,%: C 60.85; H 76.78; N 3.48.
    权利要求:
    Claims (3)
    [1]
    Claim
    1. The method of obtaining derivatives of 1,2,3,4,
    6,7, -hexahydro-11 & aH-benzo {a] quinolizine where both R 1 mean an alkyl group containing 1-4 carbon atoms or together form a methylene group;
    R 2 is a cyano or alkoxycarbonyl group in which the alkyl group contains 1-4 carbon atoms;
    R 3 is an oxy-, acetoxy-group in the a- or β-position, or their salts, characterized in that the 2-oxo compound of the general formula wherein R 1 and R 2 have the indicated meanings, are treated with a reducing agent, with the isolation of the target product or with subsequent acylation and isolation the target product in free form or in the form of salt.
    [2]
    2. The method according to π. 1, characterized in that Th <5 as a reducing agent use sodium borohydride.
    [3]
    3. The method according to PP. 1 and 2, characterized in that acetic anhydride is used as the acylating agent. ''
    类似技术:
    公开号 | 公开日 | 专利标题
    SU719499A3|1980-02-29|Method of preparing 1,2,3,4,6,7-hexahydro-11 b alpha-h-benzo|-quinolysin derivatives or their salts
    US4778891A|1988-10-18|Certain pyrano |-indolizine derivatives
    US5708020A|1998-01-13|Arylalkyl|amides
    SU691089A3|1979-10-05|Method of producing carbonyl-substituted 1-sulphonylbenzimidazoles
    SU460626A3|1975-02-15|The method of obtaining vincamine or its derivatives
    SU1745121A3|1992-06-30|Method of 3,5-dimethyl-4-methoxypyridine -2-methanol synthesis
    SU447886A1|1974-10-25|The method of obtaining protected 4,6-0-alkylidene - - -glucopyranose
    US4283401A|1981-08-11|Process for the preparation of 11-bromo-vincaminic acid ester derivatives and their use in protecting animals against cerebral hypoxy
    SU481155A3|1975-08-15|Production method - | morphinans
    SU479290A3|1975-07-30|The method of obtaining 2- | -6,7 benzomorfan
    Bryant et al.1995|A large scale synthesis of 3‐chloro‐5‐methoxypyridazine
    SU589917A3|1978-01-25|Method of preparing pyrimidine derivatives
    SU655314A3|1979-03-30|Method of obtaining naphthyridine derivatives or their stereoisomers or their salts
    SU368752A1|
    SU564813A3|1977-07-05|Method for obtaining derivatives of indoloquinolysine or their salts
    US4424361A|1984-01-03|Process for preparing polycyclic triazoles used to inhibit allergic responses
    SU584782A3|1977-12-15|Method of preparing aminoimidazoisoquinoline derivatives or salts thereof
    US4399069A|1983-08-16|Process for an enantioselective synthesis of optically active 14-oxo-E-homo-eburnane derivatives
    Bobowski1981|2′, 3′, 4′, 9′‐Tetrahydrospiro [cyclohexane‐1, 1′‐| pyrido [3, 4‐b] indol]‐2‐ones and their transformations into 2, 3, 4, 4a, 5, 6, 9, 14‐octahydro‐4a‐hydroxy‐1h, 8h‐pyrido [3, 4‐b: 2, 1‐i'] diindole‐5‐carbonitriles and 5‐substituted 2, 3, 4, 4a, 9, 14‐hexahydro‐4a‐hydroxy‐1H, 8H‐indolo [2′, 3′: 3, 4]‐pyrido [1, 2‐c] benzimidazol‐6‐| ones
    FI81799C|1990-12-10|9- or 11-substituted apovinamic acid derivatives and process for their preparation
    SU1181546A3|1985-09-23|Method of producing condensed pyrimidine derivatives as racemates or optical isomers
    SU1017167A3|1983-05-07|Process for preparing d-5-acetamido-4,5,6,7-tetrahydro-2h-benzo|pyrrole
    US2493645A|1950-01-03|Nicotinic acid-beta-picolyl-amide and process for the manufacture thereof
    JP3109903B2|2000-11-20|Asymmetric 9-aminostyryl-10-styrylanthracene derivatives and process for producing the same
    BE1004471A3|1992-12-01|NOVEL DIESTER octahydro-indolo [2,3-A] -TETRAHYDROPYRANYL [2,3-C] quinolizine RACEMIC OPTICALLY ACTIVE AND METHOD FOR PREPARING.
    同族专利:
    公开号 | 公开日
    ES470787A1|1979-02-01|
    JPS545999A|1979-01-17|
    US4193998A|1980-03-18|
    GB2000135A|1979-01-04|
    FR2394546A1|1979-01-12|
    AT363939B|1981-09-10|
    IT7868372D0|1978-06-13|
    NL7800024A|1978-12-19|
    FI65245B|1983-12-30|
    FR2394546B1|1982-07-16|
    DE2824905A1|1979-01-04|
    IT1203186B|1989-02-15|
    HU175890B|1980-11-28|
    FI781898A|1978-12-16|
    GB2000135B|1982-01-20|
    FI65245C|1984-04-10|
    ATA419478A|1981-02-15|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3053845A|1962-09-11|Benzofykedocolines |
    CH341161A|1956-02-08|1959-09-30|Hoffmann La Roche|Process for the preparation of substituted 2-hydroxy-benzo [a] quinolizines|
    FI49422C|1961-08-29|1975-06-10|Pfizer|A process for the preparation of therapeutically valuable 2-substituted benzopyridocholines and their acid addition salts.|
    US3634431A|1969-12-22|1972-01-11|Miles Lab|Acylated and alkylated derivatives of 2-aminohexahydrobenzoquinolizines|
    YU264675A|1974-10-23|1982-05-31|Chinoin Gyogyszer Es Vegyeszet|Process for obtaining benzo -quinolizidine derivatives|
    US4133812A|1975-11-21|1979-01-09|Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.|Process for producing benzo quinolizine derivatives|US4992446A|1989-09-05|1991-02-12|G. D. Searle & Co.|Tricyclic quinolizine amides|
    AU2575797A|1996-04-19|1997-11-12|Nippon Shinyaku Co. Ltd.|Benzoquinolizine derivatives and medicinal compositions|
    US7897768B2|2007-06-08|2011-03-01|General Electric Company|Method for making tetrabenazine compounds|
    JP5663309B2|2007-10-25|2015-02-04|ゼネラル・エレクトリック・カンパニイ|Fluorinated dihydrotetrabenazine ether imaging agents and probes|
    US7897770B2|2007-10-25|2011-03-01|General Electric Company|Fluorinated dihydrotetrabenazine ether imaging agents and probes|
    US7897769B2|2007-10-25|2011-03-01|General Electric Company|Intermediates for fluorinated dihydrotetrabenazine ether imaging agents and probes|
    US8053578B2|2007-11-29|2011-11-08|General Electric Company|Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes|
    US7902364B2|2007-11-29|2011-03-08|General Electric Company|Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes|
    US7910738B2|2007-11-29|2011-03-22|General Electric Company|Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes|
    US7919622B2|2007-12-07|2011-04-05|Kande Kankanamalage Dayarathna Amarasinghe|Intermediates for fluorinated tetrabenazine carbinol compounds imaging agents and probes|
    US8013161B1|2007-12-07|2011-09-06|General Electric Company|Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes|
    EP2576552A4|2010-06-01|2013-11-13|Aupex Pharmaceutical Inc|Benzoquinolone inhibitors of vmat2|
    US9550780B2|2012-09-18|2017-01-24|Auspex Pharmaceuticals, Inc.|Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2|
    CA2883641C|2012-09-18|2021-09-14|Auspex Pharmaceuticals, Inc.|Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2|
    EA201791466A1|2013-12-03|2017-11-30|Оспекс Фармасьютикалз, Инк.|METHODS OF OBTAINING COMPOUNDS BENZOHINOLINE|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    HU77CI1751A|HU175890B|1977-06-15|1977-06-15|Process for producing new 1,2,3,4,6,7-hexahydro-11-b-alpha-benzo-square bracket-a-square brecket closed-quinolyzine derivatives|
    [返回顶部]